Total Payments
$223.28
2023 Payments
$16.34
Companies
6
Transactions
10
Medicare Patients
10,562
Medicare Billing
$376,412
Payment Breakdown by Category
Food & Beverage$223.28 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $223.28 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $108.97 | 2 | $0 (2020) |
| Genentech USA, Inc. | $45.38 | 3 | $0 (2020) |
| Mission Pharmacal Company | $22.47 | 2 | $0 (2018) |
| USWM, LLC | $19.21 | 1 | $0 (2022) |
| PFIZER INC. | $16.34 | 1 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $10.91 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16.34 | 1 | PFIZER INC. ($16.34) |
| 2022 | $19.21 | 1 | USWM, LLC ($19.21) |
| 2020 | $44.61 | 3 | Genentech USA, Inc. ($33.24) |
| 2019 | $97.60 | 1 | Indivior Inc. ($97.60) |
| 2018 | $34.61 | 3 | Mission Pharmacal Company ($22.47) |
| 2017 | $10.91 | 1 | Ironwood Pharmaceuticals, Inc ($10.91) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/28/2022 | USWM, LLC | ZIMHI (Drug), Lucemyra | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/18/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: OUD | ||||||
| 10/28/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Virology & Specialty Care | ||||||
| 10/22/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Virology & Specialty Care | ||||||
| 10/29/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $97.60 | General |
| Category: OUD | ||||||
| 12/19/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Virology & Specialty Care | ||||||
| 08/06/2018 | Mission Pharmacal Company | Texacort (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Adrenocorticosteroid (topical) | ||||||
| 04/29/2018 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Analgesic, antispasmodic & antiseptic (urinary) | ||||||
| 06/20/2017 | Ironwood Pharmaceuticals, Inc | ZURAMPIC (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Rheumatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,917 | 3,727 | $269,671 | $101,222 |
| 2022 | 28 | 2,792 | 3,511 | $278,508 | $103,774 |
| 2021 | 27 | 2,387 | 3,018 | $235,136 | $92,650 |
| 2020 | 29 | 2,466 | 3,015 | $232,972 | $78,766 |
Total Patients
10,562
Total Services
13,271
Medicare Billing
$376,412
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 638 | 692 | $149,472 | $57,228 | 38.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 263 | 268 | $27,604 | $9,244 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 154 | $22,638 | $8,995 | 39.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 223 | 454 | $16,798 | $7,356 | 43.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $4,640 | $2,040 | 44.0% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 49 | 52 | $4,836 | $2,000 | 41.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 100 | 102 | $3,774 | $1,652 | 43.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 154 | 166 | $11,122 | $1,604 | 14.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 128 | 135 | $3,240 | $1,397 | 43.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 168 | 176 | $1,408 | $1,380 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 151 | 158 | $3,318 | $1,202 | 36.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,500 | $1,076 | 71.7% |
| 87088 | Bacterial urine culture | Office | 2023 | 99 | 101 | $2,222 | $800.93 | 36.0% |
| 84484 | Troponin (protein) analysis, quantitative | Office | 2023 | 55 | 59 | $2,655 | $720.98 | 27.2% |
| 82553 | Creatine kinase (cardiac enzyme) level, mb fraction only | Office | 2023 | 52 | 56 | $1,792 | $633.92 | 35.4% |
| 85379 | Coagulation function measurement, d-dimer; quantitative | Office | 2023 | 59 | 63 | $1,764 | $628.74 | 35.6% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 66 | 67 | $1,608 | $568.16 | 35.3% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 67 | 68 | $1,496 | $538.56 | 36.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 52 | 53 | $3,339 | $522.34 | 15.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,020 | $483.48 | 47.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 107 | 109 | $981.00 | $330.74 | 33.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 55 | 57 | $513.00 | $320.79 | 62.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 30 | 31 | $527.00 | $236.68 | 44.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 59 | 62 | $558.00 | $136.40 | 24.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 44 | 190 | $568.00 | $75.30 | 13.3% |
About Dr. Gary Mcbride, MD
Dr. Gary Mcbride, MD is a Addiction Medicine healthcare provider based in Jackson, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982671079.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Mcbride, MD has received a total of $223.28 in payments from pharmaceutical and medical device companies, with $16.34 received in 2023. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($223.28).
As a Medicare-enrolled provider, Mcbride has provided services to 10,562 Medicare beneficiaries, totaling 13,271 services with total Medicare billing of $376,412. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Internal Medicine
- Location Jackson, TN
- Active Since 03/07/2006
- Last Updated 09/25/2024
- Taxonomy Code 207RA0401X
- Entity Type Individual
- NPI Number 1982671079
Products in Payments
- SUBLOCADE (Drug) $108.97
- Xofluza (Drug) $45.38
- ZIMHI (Drug) $19.21
- PAXLOVID (Drug) $16.34
- Texacort (Drug) $11.82
- ZURAMPIC (Drug) $10.91
- Uribel (Drug) $10.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.